Member Info for NathanR999

Tides going out, who's been swimming without their trunks on. Some big names will get routed over the coming weeks so being our stock.down will need some context and comparison to wider market. Will need decent numbers in the quarterly update to help hold up share price in turbulence. For comparison smarteye down close to 7% this am and below 90 sek for the first time in a good few months. Nervy times for lots of different reasons and the disruptive events continue. Pestilence, war, inflation social unrest and the drums of another middle east centric war beginning to beat. Just need china to claim Taiwan with military force. Hard reset coming imho

Https://x.com/RealityBigBang/status/1818636536012775924?s=19

Https://www.linkedin.com/posts/colin-barnden-1081376_kia-ev9-driver-activity-7222206571353645056-_MBH?utm_source=share&utm_medium=member_android

Https://www.redeye.se/events/1016188/live-q-smart-eye-7

*BURN margin. Fat fingers again. Bloody hate phone keyboards

I feel some pointy questions for the smarteye quarterly investor video call. And hopefully some more to Jacob at Redeye for.him to obfuscate on. Smarteye are gonna have some trickier q's frommoem and tier 1 partners. This will. Urn margin for the engineering to right issues once in field. There by the grace of God etc. Hopefully higher volume dms in mirror won't get reviews like this. Crosses fingers.....

Ultimately for the penny pinching in auto it will be price. We may have a price we won't sell at, smarteye, cipia or tobii maybe don't see it that way and price to.win regardless. That is a path to ruin, in the field I work in we see people do that and it doesn't end well for both parties. Cashflow is poor for the company selling goods or even negative when everything is factored like overheads. For the purchaser they have to suffer suboptimal or even incorrect product and need to recontract resulting in their own costs eating into any perceived saving they though they had , potential for reputation damage and if they recontract new bidders may see the value and need they no have and price may go up as the poor cheap alternative(s) are.too risky leaving the prime supplier to set the price. Bit over simplistic in dynamics but ultimately price is the.play here with the two mentioned stories overlaid. Sw defined vehicle will be a distant memory when penny drops. So.much.money will be wasted barking up that tree by oems

Some context for why Biomerieux might value acquisition.

They bought Biofire/idaho for c500m usd in 2013 tenfold into thier molecular portfolio which at the time was minor part of portfolio. Biofire product line was 40m usd a year in sales. In 2023 Biofire was tracking close to 1bill usd as part of 3bil revs. Sequencing for Biomerieux could easily be double that in Clinical Microbiology, Food Microbiology and Industrial Microbiology alone and then add in all theranostics and life science sales. They will want to acquire of course at best price and IPO price equivalent may mean they need to take on more debt or rights issue. Very exciting times esp if you buy at this price. 2 or 3 x definately feasible. Other aquirers also possible. I wouldn't rule out danaher adding to their diagnostic portfolio alongside cepheid,beckman etc.

Smarteye also use IR. It's the pattern of on and off, illuminator position and number of lamps that vary. Cipia and tobii also use ir I think.

Genesis is in thr hyundai kia box so prob smarteye

I think this is nailed on to be a Biomerieux portfolio company within the next 12 months. I would say their aquisiation price will be around thier investment price unless current share price returns either to that price post next results or advances further to regain ground on ipo price. They took a similar route.to.acquire specific diagnostics previously. I think they see this as a key product for thier sepsis/biodiversity and ast area and in that market i could see this being called VitekSeq or similar. Buy all day long right up to £2.00 per share.

A second question might be "we know Martin Krantz smarteye have actively intimated that Korean oems,volvo polestar and mitsubishi cars are involved with Smarteye for interior sensing and dms during various short video posted during tech and auto shows so on the basis of some significant issues highlighted in dms in these brands what cost implications or contingencies do Smarteye have exposure to in light of this new information. Will ramp up be further delayed or future model expansion heralded in many quarterly presentations supporting the investment case and value of 'won' business now be revised downwards as OEMs exposed reconsider dms/OMS award choices.

Https://www.linkedin.com/posts/colin-barnden-1081376_dms-mitsubishi-software-activity-7221119761978454016-ROKT?utm_source=share&utm_medium=member_android

Will be interesting q and a session post smarteye next q market report. Definately some questions a potential investor might seek to ask to reassure themselves on a Smarteye investment. One might be "based on reviews on some vehicles dms performance such as mitsubishi triton, volvo ex30 and Kia ev9 can smarteye categorically state here and now that these are not smarteye vehicles... "

Wonder ifsome awards close to be being announced are being rethought based on some of these disclosures. Need some references regarding our stuff before we crow too hard mind.

Not sure which company in UK will drop 30m for a distribution company with a very small manufacturer bolted on. Not if forced sale. There maybe piecemeal sales in Ireland with accusay, LD in Germany but UK would be the tricky one. Non of the current UK lab distributors are likely to raise the capital needed off thier current scale. They would be more interested in pinching one of distribution rights esp liofichem or Purcell rather than swallowing the headcount and facilities. A tricky one to resolve , I wasn't happy with the aquisition in the first place. The disposal will likely be a net loss in my mind unless anyone here has a different outcome model or some other reasoning that gets the money back or even a small uplift. Thoughts?

Tbf. The comments on the video do suggest some disappointment with the dms from ?owners ? Competitors ?contrarian reactionarys . Lots to shake in this space.

Biggest risk is oems and owners push back on nanny tech due ill functioning or lesser implementations regardless of supplier. The dms supplier can only do so.much either directly or via tier 1 partner offering the tech solution components that work with the software.

21st Aug is smarteye quarterly report and analyst presentation q and a. Maybe an opportunity to ask a few awkward questions about some if the cars he pointed at during various walkabouts. Particulary volvo and mitsubishi. Not that it will make much difference but will make me feel better.

Viral reviews can make or break sales of cars. Do i recall correctly that back in the day Jeremy Clarkson absolutely trashed a version of the vectra or similar vauxhall large saloon and that decimated UK sales? In use testing that reveals bad deal breakers don't usually end well for the product. Software could be patched to resolve but the optical.path upgrade can't be done until model refresh or a recall. Buy cheep buy twice. Guidance for life

The aussie guy is right, the outright frustration of a good product ruined is plain to see. A lot more reviews of cars will be in the wild over next year for both see, cipia, tobii and seye and it will be interesting to see what people make of the tech on wider adoption regardless of supplier. These overheads might be well spent and the long game we clean up as long as we don't get reviews like that also.

The lower share count does help in a minor way as small movements on any buying flurries here with see get a bit amplified at SEYE when similar occurs. They are listed on a sub of NASDAQ and often wondered if NASDAQ might take over AIM. Would that improve acces to capital and better liquidity - no idea. Still prefer see over seye and reiterate both will do OK but Seye could 'get found out' in coming quarters but SEE need to be.the choice for the Rfqs for new oem.platforms post 2026 and into 2030s. Valuation in a perfect world should much higher but it's what it is - marketing product to oems and Tier 1s and the relationships we are fostering in valeo, magna and collins in aviation are top notch. Guardian could be the golden egg but needs.more volume signed but also taking the monitoring - that bit is opaque at the moment. Could be tremendous or a damp squib without more positive signals. Aviation is an unknown and out of our hands really and will be down to Collins timescales - again could be great but 5 years away for true scale to be visible. Cars on road heading in right direction and the technical expertise we have and integrated advice to OEMs if they are expansive in thought enough to.work.closely with us then a great product is.more.likely. software at a price and a hope ends up with crap reviews and poor functions. I have picked my horse and wait with bated breath for execution. Still think acquired by 2026 but c 3bn max.